Rigel Pharmaceuticals files an NDA for fostamatinib in patients with chronic and persistent immune thrombocytopenia.
FDA releases a Form-483 from a 2/7-17 inspection at Abbotts St. Jude Medical manufacturing facility in Sylmar, CA, that found Quality System Regulatio...
Federal Register notice: FDA announces a 5/8-9 Pharmacy Compounding Advisory Committee meeting that will hearing compounding updates and discuss addin...
OncoMed Pharmaceuticals says results from a Phase 2 trial evaluating tarextumab failed to meet its primary endpoint (progression free survival) or sec...
FDA approves Genentechs Lucentis (ranibizumab injection) 0.3 mg for the monthly treatment of all forms of diabetic retinopathy.
FDA Review posts the latest Federal Register notices for the week ending 4/14/2017.
In a move to avoid layoff notices sent to FDA staff working under the agencys user fee programs, Senate and House health committee leaders release a b...
Standard Homeopathic recalls all lots of Hylands Baby Teething Tablets and Hylands Baby Nighttime Teething Tablets sold in retail stores.